Mmmm, she seems to be indicating that they don't know (ie: they're not trained) in how to undertake a trial as the issue. Ie: the research and operating (literally..) environments, have very, very few bridges, between them. Silos of practice, rather than willingness, as the issue.
Cell Therapy News/Articles, page-9521
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.04 |
Change
0.073(7.47%) |
Mkt cap ! $1.196B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.06 | 99.0¢ | $3.963M | 3.854M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 58335 | $1.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 48480 | 17 |
View Market Depth
| Last trade - 14.55pm 04/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |